No Detail Found!

Efficacy of argon plasma coagulation in gastric vascular ectasia in patients with liver cirrhosis

Author(s)
Muhammad Afzal Bhatti Department of Gastroenterology, Shaikh Zayed Hospital, Lahore, Pakistan.
Anwaar A. Khan Department of Gastroenterology, Shaikh Zayed Hospital, Lahore, Pakistan.
Altaf Alam Department of Gastroenterology, Shaikh Zayed Hospital, Lahore, Pakistan.
Arshad K. Butt Department of Gastroenterology, Shaikh Zayed Hospital, Lahore, Pakistan.
Farzana Shafqat Department of Gastroenterology, Shaikh Zayed Hospital, Lahore, Pakistan.
Kashif Malik Department of Gastroenterology, Shaikh Zayed Hospital, Lahore, Pakistan.
Joher Amin Department of Gastroenterology, Shaikh Zayed Hospital, Lahore, Pakistan.
Waqar Shah Department of Gastroenterology, Shaikh Zayed Hospital, Lahore, Pakistan.
Abstract
Objective: To determine the efficacy of Argon Plasma Coagulation (APC) in terms of improvement in hemoglobin level and disappearance of telangiectasia as endoscopic treatment for Gastric Antral Vascular Ectasia (GAVE) and Diffuse Antral Vascular Ectasia (DAVE) syndrome in liver cirrhosis. Study Design: Quasi experimental study. Place and Duration of Study: Department of Gastroenterology and Hepatology of Shaikh Zayed Hospital/ Federal Postgraduate Medical Institute, Lahore, from January, 2006 to July, 2007. Methodology: Cirrhotic patient with gastric vascular ectasia were enrolled and followed-up for 18 months with repeated sessions of APC. Efficacy of APC was evaluated on the basis of patient's symptoms, transfusion requirements and hemoglobin levels. APC was performed by using ERBE generator set at 60 W and flow rate 2.0 L/min using primarily endfiring probes. Results: Fifty patients were enrolled in the study. Mean age was 55.78+1.24 years with 32 males and 18 females giving a male to female ratio 1.7:1. Forty two patients were in Child's Class C and 8 in Child's Class B. Presenting complaints were malena and anemia. Two hundred and fifty three APC sessions were carried out; mean 5.06+1.5 sessions per patient. Mean follow-up period after the last session was 8.5+3.7 months. Mean increase in the hemoglobin level was 1.35+0.24 g/dl. There was no death of any patient during the study period. Conclusion: Treatment with APC is an effective and safe method to decrease blood loss in patients with GAVE and DAVE.
Publication Details
Page(s) 219-222
DOI DOI not available
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 19, Issue: 4, Year: 2009

Request the full text from PASTIC

Keywords
Cirrhosis, Argon plasma coagulation, Gastric antral vascular ectasia (GAVE), Diffuse antral vascular ectasia (DAVE)
0

Citations

0

Downloads

120

Views